Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner- city adolescents

Journal of Adolescent Health

Volumn 23, Issue 2, 1998, Pages 81-88

  Polaneczky, Margaret ^a   Liblanc, Michelle ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Adolescence; Compliance; Contraception; Medroxyprogesterone acetate; Pregnancy; Pregnancy in Adolescence

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADOLESCENT; ADOLESCENT PREGNANCY; ADULT; ARTICLE; CONTRACEPTION; DRUG IMPLANT; DRUG USE; DRUG WITHDRAWAL; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MENSTRUATION DISORDER; PATIENT COMPLIANCE; PRIORITY JOURNAL; SIDE EFFECT; UNITED STATES; WEIGHT GAIN;

ADOLESCENT PREGNANCY; ADOLESCENTS; ADOLESCENTS, FEMALE; AGE FACTORS; AMERICAS; CENTRAL CITY; CONTRACEPTION; CONTRACEPTION CONTINUATION; CONTRACEPTION TERMINATION; CONTRACEPTIVE AGENTS, FEMALE--SIDE EFFECTS; CONTRACEPTIVE AGENTS, PROGESTIN--SIDE EFFECTS; CONTRACEPTIVE AGENTS--SIDE EFFECTS; CONTRACEPTIVE METHODS; CONTRACEPTIVE USAGE; DEMOGRAPHIC FACTORS; DEPO-PROVERA--SIDE EFFECTS; DEVELOPED COUNTRIES; ECONOMIC FACTORS; FAMILY PLANNING; FERTILITY; GEOGRAPHIC FACTORS; INJECTABLES; LOW INCOME POPULATION--WOMEN; MEDROXYPROGESTERONE ACETATE--SIDE EFFECTS; NEW YORK; NORTH AMERICA; NORTHERN AMERICA; OBSTACLES; ORGANIZATION AND ADMINISTRATION; POPULATION; POPULATION CHARACTERISTICS; POPULATION DYNAMICS; REPRODUCTIVE BEHAVIOR; RESEARCH METHODOLOGY; RESEARCH REPORT; RETROSPECTIVE STUDIES; SOCIAL CLASS; SOCIOECONOMIC FACTORS; SOCIOECONOMIC STATUS; SPATIAL DISTRIBUTION; STUDIES; UNITED STATES; URBAN SPATIAL DISTRIBUTION; URBANIZATION; YOUTH;

ADOLESCENT; ADOLESCENT HEALTH SERVICES; ADULT; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; NEW YORK CITY; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY IN ADOLESCENCE; URBAN POPULATION;

EID: 0032146793     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-139X(98)00014-7     Document Type: Article

References (27)

1. 1. Frost J, Forrest JD. Understanding the impact of effective teenage pregnancy prevention programs. Fam Plann Perspect 1995;27:188-95.
2. 2. American College of Obstetrics and Gynecology. Adolescent pregnancy prevention programs. ACOG, Washington DC, 1997.
3. 3. Balassone ML. Risk of contraceptive discontinuation among adolescents. J Adolesc Health Care 1989;10:527-32.
4. 4. Emans J, Grace E, Woods E, et al. Adolescent's compliance with the use of oral contraceptives. JAMA 1987;257:3377-81.
5. 5. Jones EF, Forrest JD. Contraceptive failure rates in the United States: Revised estimates from the 1982 National Survey of Family Growth. Fam Plann Perspect 1989;21:102-9.
6. 6. Joffe A. Adolescents and condom use. Am J Dis Child 1993; 147:746-54.
7. 7. Coupey S. New hormonal contraceptive options for adolescents. In: Goldfarb AF, Ed. Clinical Problems in Pediatrics and Adolescent Gynecology. New York: Chapman and Hall, 1996: 77-88.
8. 8. Polaneczky M, Slap G, Forke C, et al. The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers. N Engl J Med 1994;331:1201-6.
9. 9. Crosby UD, Schwartz BE, Gluck KL et al. A preliminary report of Norplant implant insertions in a large urban family planning program. Contraception 1993;48:359-66.
10. 10. Glantz S, Schaff E, Campbell-Heider N, et al. Contraceptive implant use among inner city teens. J Adolesc Health 1995;16: 389-95.
11. 11. Kolata G. Will the lawyers kill off Norplant? The New York Times. May 28, 1995; Section C:1.
12. 12. Cromer BA, Blair JM, Mahan JD, et al. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 1996;129:671-6.
13. 13. Smith RD, Cromer BA, Hayes JR, et al. Medroxyprogesterone acetate (Depo-Provera) use in adolescents: Uterine bleeding and blood pressure patterns, patient satisfaction and continuation rates. Adolesc Pediatr Gynecol 1995;8:24-8.
14. 14. Cromer BA, Smith D, Blair JM, et al. A prospective study of adolescents who choose among levonorgestrel implants (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive as contraception. Pediatrics 1994; 94:687-94.
15. 15. Harel Z, Biro FM, Kollar LM. Depo-Provera in adolescents: Effects of early second injection or prior oral contraception. J Adolesc Health 1995;16:379-84.
16. 16. Sangi-Haghpeykar H, Poindexter AN, Bateman L, et al. Experiences of injectable contraceptive users in and urban setting. Am J Obstet Gynecol 1996;88:228-33.
17. 17. Polaneczky M, Guarnaccia M, Alon J, et al. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population. Fam Plann Perspect 1996;28:174-8.
18. 18. Ipsen J, Feigl P. Bancroft's Introduction to Biostatistics, 2nd edition. New York: Harper & Row, 1992:153-62.
19. 19. Lee ET. Statistical Methods for Survival Analysis, 2nd edition. New York: Wiley, 1992:105-7.
20. 20. Sokal RR, Rohlf FJ. Introduction to Biostatistics, 2nd edition. New York: WH Freeman, 1987:112-4.
21. 21. Zar JH. Biostatistical Analysis, 2nd edition. Englewood Cliffs, NJ: Prentice-Hall, 1984:150-3.
22. 22. Odell C, Forke C, Polaneczky M, Sondheimer S, et al. Depot medroxyprogesterone acetate versus oral contraceptive use by post partum adolescents. Obstet Gynecol 1998;91:609-614.
23. 23. Madlon-Kay DJ. The effectiveness of a mail reminder system for depot medroxyprogesterone injections. Arch Fam Med 1996;5:234-36.
24. 24. Diaz S, Croxatto HB, Pavez M, et al. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants. Contraception 1990;42:97-109.
25. 25. Said S, Sadek W, Rocca M, et al. Clinical evaluation of the therapeutic effectiveness of ethinyl estradiol and oestrone sulfate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. Hum Reprod 1996;11(Suppl 2):1-13.
26. 26. Levine AS, Holmes MM, Haseldon C, et al. Subdermal implants (Norplant) continuation rates among adolescents and adults in a family planning clinic. J Pediatr Adol Gynecol 1996;9:67-70.
27. 27. Levinson RA. Contraceptive self-efficacy: A perspective on teenage girls' contraceptive behavior. J Sex Res 1096;22:347-69.